Columnist: Take generic prices off the roller coaster

03/19/2013 | Los Angeles Times (tiered subscription model)

Prices of the same generic treatments can vary widely at the same pharmacies, and the FDA should get involved to make the system more transparent, David Lazarus writes. The reasons behind roller-coaster prices can be complicated and include supply chain changes, different costs for different manufacturers, and pricing decisions by makers, wholesalers and retailers.

View Full Article in:

Los Angeles Times (tiered subscription model)